Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Glycoprotein of Zaire ebolavirus is an essential structural protein responsible for mediating viral entry through receptor binding and membrane fusion. Its complex structure—including heavy glycosylation—enables immune evasion but also provides key targets for neutralizing antibodies, vaccines, and therapeutics. Recombinant versions are widely used in research settings due to their central role in infection biology.
Inhibition of receptor binding, disruption of membrane fusion
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycoprotein (GP).